Leidy Isenalumhe, MD
Internal Medicine · Tampa, FLNPI 1801057310
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $25,374 of the $28,865 with a category attached, or 87.9%. Jazz Pharmaceuticals Inc. accounts for 91.8% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $14,758, more than ten times the $157 reported in 2019. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $1069.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$27K
- Amgen$939
- AbbVie$250
- Ipsen Biopharmaceuticals, Inc$150
- Pfizer$142
- Pharmacyclics LLC, An Abbvie Company$129
- plus $754 from 9 others
Across 11 payments — averaging $67,113 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Acerta Pharma LLC$738K
What the payments were for
- Consulting fees$25,37488%
- Speaking & faculty fees$1,5875%
- Food & beverage$1,9057%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 6 | $26,503 |
| Amgen | 4 | $939 |
| AbbVie | 2 | $250 |
| Ipsen Biopharmaceuticals, Inc | 1 | $150 |
| Pfizer | 2 | $142 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $129 |
| AstraZeneca | 1 | $127 |
| Abbott | 1 | $126 |
| Genmab U.S., Inc. | 1 | $121 |
| Morphosys, US Inc. | 3 | $102 |
| ADC Therapeutics America, Inc. | 1 | $69 |
| Global Blood Therapeutics, Inc. | 1 | $68 |
| Lilly USA, LLC | 1 | $60 |
| Beigene USA, Inc. | 1 | $51 |
| Seagen Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$28,865 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Entecavir | 11 | $298 |
| Acyclovir | 21 | $265 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Tampa
- Andrew KuykendallTampa$322K
- Jhanelle GrayTampa$229K
- Anitha ReddyTampa$224K
- Benjamin CreelanTampa$212K
- Anne HermannTampa$139K
- Mark LaflammeTampa$119K
- Shahla BariTampa$56K
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.